I listened into the webinar, quite interesting. You can tell a lot by how people speak and what they say (or don't say).
They're definitely setting themselves for huge expansion, and they've already broken into UK and US, which they did note was the hardest part. Now that they have a customer in each region, getting others becomes a lot easier. So they should be able to build on that, with US having considerably higher contracts and UK I believe lots of smaller ones. Also the current international trajectory is very similar to how AUS started in terms of the slope, so if it follows the same pattern, there will be massive growth (especially as international markets are so much larger).
The road worker safety makes business sense - they're essentially diversifying and have probably realised they have too many eggs in one basket. The fact that they have an existing partnership already with Fulton Hogan is promising. The Victoria contract will be up next year, so will be interesting to see if they put out a tender, or if they opt-in for the extra 1 year with one task (which they have the option of). For the fact that they have everywhere but there and Tassie, you would think the VIC government would consider.
But the main goal here is international market, that's crystal clear. Getting those ISO certs were critical in that sense.
Escrow holdings was released today and there's been no selling. It's worth mentioning that the 2 largest holders (Jannink and Powertron) haven't had any restrictions at all and could have sold at any time. They have not sold anything which says a lot.
- Forums
- ASX - By Stock
- ACE
- Ann: Acusensus FY24 Investor Presentation
ACE
acusensus limited.
Add to My Watchlist
0.53%
!
95.5¢

Ann: Acusensus FY24 Investor Presentation, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
95.5¢ |
Change
0.005(0.53%) |
Mkt cap ! $133.9M |
Open | High | Low | Value | Volume |
95.5¢ | 95.5¢ | 95.5¢ | $27 | 28 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1483 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 800 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1483 | 0.955 |
5 | 78843 | 0.950 |
1 | 147 | 0.925 |
1 | 147 | 0.920 |
1 | 5213 | 0.900 |
Price($) | Vol. | No. |
---|---|---|
0.985 | 1100 | 1 |
0.990 | 310 | 1 |
1.015 | 17356 | 2 |
1.020 | 500 | 1 |
1.040 | 7403 | 1 |
Last trade - 12.15pm 01/07/2025 (20 minute delay) ? |
Featured News
ACE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online